In vitro-derived platelets: the challenges we will have to face to assess quality and safety
Platelet transfusions are given to patients in hospital who have a low blood platelet count (thrombocytopenia) either because of major bleeding (following trauma or surgery) or because the bone marrow production of platelets is impaired often due to chemotherapy, infiltration with malignant cells, f...
Main Authors: | S. Mookerjee, H. R. Foster, A. K Waller, C. J. Ghevaert |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-08-01
|
Series: | Platelets |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09537104.2020.1769051 |
Similar Items
-
In Vitro Innovation of Tendon Tissue Engineering Strategies
by: Maria Rita Citeroni, et al.
Published: (2020-09-01) -
Recent Developments in In Vitro Spermatogenesis and Future Directions
by: In Ki Cho, et al.
Published: (2023-09-01) -
Morphometric parameters and photosynthetic performance of in vitro propagated pineapple
by: Marcelo de Souza Marchi, et al.
Published: (2022-11-01) -
Bioreactors, scaffolds and microcarriers and in vitro meat production—current obstacles and potential solutions
by: Magdalena Kulus, et al.
Published: (2023-09-01) -
Bioengineered Living Bone Grafts—A Concise Review on Bioreactors and Production Techniques In Vitro
by: Paulina Kazimierczak, et al.
Published: (2022-02-01)